CIPOLLONE, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 9.545
EU - Europa 9.352
AS - Asia 4.955
SA - Sud America 286
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 10
Totale 24.192
Nazione #
US - Stati Uniti d'America 9.465
IT - Italia 2.371
SG - Singapore 2.096
CN - Cina 1.528
IE - Irlanda 1.506
SE - Svezia 1.122
UA - Ucraina 1.115
DE - Germania 798
TR - Turchia 792
GB - Regno Unito 775
FR - Francia 643
FI - Finlandia 401
IN - India 318
BR - Brasile 257
RU - Federazione Russa 257
NL - Olanda 91
HK - Hong Kong 81
CA - Canada 61
AT - Austria 59
BE - Belgio 47
VN - Vietnam 42
CZ - Repubblica Ceca 26
PL - Polonia 24
ES - Italia 18
LT - Lituania 17
IR - Iran 15
MX - Messico 15
EG - Egitto 13
EU - Europa 11
IL - Israele 11
CH - Svizzera 10
JP - Giappone 10
RO - Romania 9
AR - Argentina 8
BD - Bangladesh 8
EE - Estonia 8
GR - Grecia 8
AU - Australia 7
AL - Albania 6
TH - Thailandia 6
DK - Danimarca 5
EC - Ecuador 5
NO - Norvegia 5
SI - Slovenia 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CO - Colombia 4
HU - Ungheria 4
ID - Indonesia 4
IQ - Iraq 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PH - Filippine 2
PS - Palestinian Territory 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PY - Paraguay 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 24.192
Città #
Chandler 1.869
Singapore 1.467
Dublin 1.466
Jacksonville 1.333
Princeton 633
Southend 575
Ashburn 465
Izmir 437
The Dalles 406
Nanjing 355
Beijing 305
Munich 303
Wilmington 276
Santa Clara 275
Ann Arbor 262
Chieti 251
Pescara 248
Dearborn 221
Cambridge 204
New York 198
Altamura 195
Helsinki 164
Boardman 158
Los Angeles 146
Nanchang 134
Rome 104
Milan 101
Woodbridge 95
Washington 81
Shenyang 79
Hong Kong 68
Tianjin 66
Nuremberg 64
Hebei 62
Jiaxing 57
Kunming 51
Hangzhou 48
Brussels 46
Norwalk 43
Changsha 40
Seattle 40
Jinan 39
Dong Ket 37
Vienna 37
Florence 33
Falls Church 32
Grevenbroich 32
Toronto 31
Ningbo 30
Houston 27
Moscow 27
Zhengzhou 25
London 23
Brno 22
Turku 21
Augusta 20
Bologna 20
Frankfurt am Main 20
Lappeenranta 19
Orange 19
San Francisco 19
Guangzhou 18
São Paulo 18
Changchun 17
Lanzhou 17
Leawood 17
Auburn Hills 16
Padova 15
Rio de Janeiro 15
San Mateo 15
Taizhou 15
Turin 15
Amsterdam 14
Bari 13
Brooklyn 13
Düsseldorf 13
Ottawa 13
San Vito Chietino 13
Spoltore 13
Chicago 12
Council Bluffs 12
Teramo 12
Warsaw 12
Genoa 11
Hefei 11
Montreal 11
Paris 11
Shanghai 11
Avellino 10
Campobasso 10
Fairfield 10
Frontone 10
Romola 10
Venice 10
Castignano 9
Stockholm 9
Camerino 8
Foggia 8
Kocaeli 8
Monmouth Junction 8
Totale 14.407
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 488
Utilizzo della Ceus nella diagnosi differenziale delle lesioni spleniche: una milza pseudonodulare. 310
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 210
MicroRNA profiling in migraine without aura: Pilot study 186
Impact of migraine on fibromyalgia symptoms 181
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 181
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 142
Attitudes Towards and Knowledge About Lesbian, Gay, Bisexual, and Transgender Patients Among Italian Nurses: An Observational Study 135
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 132
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 126
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 124
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 123
Allergens in Occupational Allergy: Prevention and Management – Focus on Asthma 123
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 122
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 119
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 117
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 117
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 117
A prothrombotic state 116
A unique microRNA signature associated with plaque instability in humans. 111
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 111
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 110
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 110
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 109
Antibiotic use and associated factors in a large sample of hospitalized older people 109
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 108
A unique microRNA signature associated with ischemic stroke in humans 107
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 107
Allergooncology: an expanding research area 107
Ultramicronized palmitoylethanolamide reduces viscero-visceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells 105
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 104
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 104
microRNA profiling in atherosclerosis, diabetes, and migraine 104
Erratum: Insight into B5-I spinal interneurons and their role in the inhibition of itch and pain 104
Co-occurrence of pain syndromes 104
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 102
Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab 102
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 102
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 101
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases 101
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 101
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache 100
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 99
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 99
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 98
Association between 5-lipoxygenase expression and plaque instability in humans. 97
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 95
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 95
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 94
Guidelines enforcement and clinical outcome 94
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 94
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease 93
Prognostic value of morning surge of blood pressure in middle-aged treated hypertensive patients 93
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 92
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 92
Role of microRNAs in the modulation of diabetic retinopathy. 92
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 92
The role of nitric oxide in the development of diabetic angiopathy. 91
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 91
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 91
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 91
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 91
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 90
Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk. 90
Novel determinants of plaque instability. 90
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 90
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 89
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 89
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 89
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 88
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 88
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 87
MicroRNA e ipertensione: avanzando a “piccoli” passi verso la comprensione della patologia 87
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 87
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 87
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 86
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 86
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 86
Canakinumab in a subgroup of patients with COVID-19 86
Pathological Gambling among Italian Nursing Students 86
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 85
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 85
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 85
Tricuspid valve endocarditis complicated by septic pulmonary embolism in an intravenous drug user 85
The (K+)ey of the problem 85
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 85
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 84
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 84
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 84
Health literacy among caregivers of patients with heart failure: A multicentre cross-sectional survey 84
Need for Deprescribing in Hospital Elderly Patients Discharged with Limited Life Expectancy: The REPOSI Study 84
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 83
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 83
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 83
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 83
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 83
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 83
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 82
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 82
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 82
Totale 10.721
Categoria #
all - tutte 115.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020459 0 0 0 0 0 0 0 0 0 0 389 70
2020/20211.933 262 32 289 61 144 358 61 65 184 221 102 154
2021/20221.741 70 46 27 300 145 59 64 112 158 66 206 488
2022/20235.223 413 721 317 520 499 994 294 394 644 80 189 158
2023/20242.904 194 90 196 100 211 860 584 129 48 109 52 331
2024/20255.927 381 1.164 938 186 228 339 463 429 773 379 647 0
Totale 25.404